CCM
AUPH icon

CTC Capital Management’s Aurinia Pharmaceuticals AUPH Stock Holding History

CTC Capital Management’s Portfolio AUPH Stock Details AUPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-12,800
Closed -$158K – 87
2022
Q1 		$158K Buy
+12,800
New +$198K 0.43% 80

Other funds holding AUPH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

CTC Capital Management's AUPH Position: Q2 2022 in Review

CTC Capital Management sold out of Aurinia Pharmaceuticals (AUPH) in Q2 2022, closing a stake of 12,800 shares — an estimated $158K sold.

CTC Capital Management first reported a position in AUPH in Q1 2022 and held it in 1 quarter. The position peaked at $158K in Q1 2022. 199 funds tracked by Wall St. Rank hold AUPH as of Q2 2022.

  • CTC Capital Management reported no remaining Aurinia Pharmaceuticals position as of Q2 2022 after selling out during the quarter.
  • CTC Capital Management sold 12,800 Aurinia Pharmaceuticals shares in Q2 2022, an estimated $158K.
  • CTC Capital Management first reported a position in Aurinia Pharmaceuticals in Q1 2022 and held it in 1 quarter.
  • CTC Capital Management's Aurinia Pharmaceuticals position peaked at $158K in Q1 2022.
  • 199 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q2 2022.

Based on CTC Capital Management's 13F filing for Q2 2022, filed 5 Aug 2022.